Clinical Trials Directory

Trials / Unknown

UnknownNCT06103396

Treatment of Nonunion Fractures With Mesenchymal Stromal Cells (MSCs)

Treatment of Nonunion After Fractures (Pseudoartrosis) Using Mesenchymal Stromal Cells (MSCs)

Status
Unknown
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Instituto Venezolano de Investigaciones Cientificas · Academic / Other
Sex
All
Age
10 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to evaluate the bone regeneration capacity of BM-MSC (Bone marrow mesenchymal stromal cells), in patients with nonunion. BM-MSC cultured are seeded on a collagen scaffold, included into autologous platelet-rich plasma (PRP) clot, and implanted in the nonunion bone defect.

Detailed description

Nonunion (pseudoarthrosis) is one of the most serious complications of bone fracture. Even though different treatments have been used to repair nonunion bone defects, most of them have limitations, like morbidities, limited supply, frequent treatment failure, and high cost. Based on the knowledge that MSC have multipotential capacity of differentiation into bone, cartilage, fat, and endothelial cells, and also, play a key role in the process of bone formation and fracture repair. In this study, we evaluated the use the bone regeneration capacity of autologous or allogeneic BM-MSC, as a potential therapeutic strategy to induce formation of new bone tissue and fracture healing. A bioengineering construct, constituted by MSCs and a collagen scaffold, is incorporated into platelet rich plasma (PRP) clot, wich is implanted at the nonunion site defect.

Conditions

Interventions

TypeNameDescription
BIOLOGICALTransplantation of autologous MSCs in nonunion fractureAt surgery, fibrotic tissue is removed from the nonunion sites. MSCs/Col/PRP clots are implanted in the site of nonunion. Patients received conventional orthopedic treatment as they needed (osteotomy, external and/or internal fixation systems, etc.)
BIOLOGICALTransplantation of allogeneic MSCs in nonunion fractureAt surgery, fibrotic tissue is removed from the nonunion sites. MSCs/Col/PRP clots are implanted in the site of nonunion. Patients received conventional orthopedic treatment as they needed (osteotomy, external and/or internal fixation systems, etc.)

Timeline

Start date
2018-01-30
Primary completion
2022-01-30
Completion
2024-12-30
First posted
2023-10-26
Last updated
2023-10-31

Locations

1 site across 1 country: Venezuela

Source: ClinicalTrials.gov record NCT06103396. Inclusion in this directory is not an endorsement.